Literature DB >> 3644825

Direct radioimmunoassay of rat urinary kallikrein: its application to the determination of active and inactive kallikrein concentration after HPLC analysis.

J P Girolami, J L Bascands, C Pecher, J M Suc.   

Abstract

Rat urinary kallikrein (RUK) was purified to apparent homogeneity by a three-step procedure and antibodies were raised in rabbits. Renal kallikrein exists as an active and an inactive form. A specific radioimmunoassay (RIA) was developed to measure directly the total kallikrein. The antibody used in this radioimmunoassay recognized both forms. No cross reactivity was detected with trypsin, esterase A or human urine. When iodinated rat urinary kallikrein was used, the detection range was between 0.125 and 16 ng with 6.5% intraassay variation and 8.1% between assay variation. Intrarenal kallikrein was measured in renal tissue after homogeneisation and solubilisation. Correlations between this RIA and the kininogenase activity or the amidolytic activity were highly significant. Since kallikrein exists as an inactive precursor the direct measurement of the total immunoreactive protein differs from activities determinations. An HPLC ion exchange system has been developed to separate active and inactive forms directly from urine, with a recovery of 79 +/- 11%. This procedure permits measurement of inactive forms. Rat urine contains as much inactive kallikrein as active kallikrein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3644825     DOI: 10.1080/01971528708063057

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  5 in total

1.  Immunolocalization of renal kallikrein-like substance in rat urinary bladder.

Authors:  C Orfila; G Bompart; J C Lepert; J M Suc; J P Girolami
Journal:  Histochem J       Date:  1993-09

2.  Evidence for intrarenal kallikrein storage during chromate-induced acute renal failure in rat.

Authors:  C Orfila; J M Suc; J P Girolami
Journal:  Histochemistry       Date:  1992

3.  Short lasting increase in urinary specific kallikrein activity during long term administration of furosemide.

Authors:  J L Bascands; J P Girolami; C Pecher; G Cabos; J P Moatti; J M Suc; Y Manuel
Journal:  Agents Actions       Date:  1987-12

4.  Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats.

Authors:  C Orfila; G Bompart; J C Lepert; J M Suc; J P Girolami
Journal:  Histochem J       Date:  1993-10

5.  Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

Authors:  C Damase-Michel; G Bompart; G Durrieu; J L Montastruc; P Montastruc; J P Girolami
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.